Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
AGENUS (NASDAQ: AGEN) Delayed: 6.68 --0 (-0%)
Previous Close $6.68    52 Week High $7.49 
Open $6.68    52 Week Low $2.61 
Day High $6.68    P/E N/A 
Day Low $6.68    EPS $-1.10 
Volume 20,412       

(NASDAQ: GANX) Delayed: 1.33 --0 (-0%)
Previous Close $1.33    52 Week High $ 
Open $1.33    52 Week Low $ 
Day High $1.33    P/E N/A 
Day Low $1.33    EPS $ 
Volume 1